Startup Mahzi Therapeutics targets autism, epilepsy related rare genetic brain disorders - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

How former $RARE employees, academics, patient groups and VCs are targeting autism, epilepsy and other genetic brain disorders

The company has 10 employees.At the center of the disorder is a gene called"WW domain containing oxidoreductase," or WWOX, that encodes for a protein that plays a role in brain development. When that protein is deficient, it causes WOREE syndrome, or"WWOX-related epileptic encephalopathy."Children diagnosed with the extremely rare mutation can develop seizures that can't be treated by drugs — what's known as refractory epilepsy.

With its MZ-9138 program, Mahzi looks to change that prognosis for children with WOREE as well as those with a slightly less severe form which presents at around 10-12 months of age. Mahzi is making the vector, an adeno-associated virus, and will start investigational new drug studies once it is ready, Weiss said. It could be in the clinic in 2024.

Mahzi's patient foundation and academic collaborations also are clear with the other two programs it has disclosed on its website.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 78. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Rezo Therapeutics, Prosper Marketplace score $75M venture rounds - San Francisco Business TimesThe Thanksgiving holiday didn't stop a drug developer and an online lender from each raising a large new round.
Fonte: SFBusinessTimes - 🏆 78. / 68 Consulte Mais informação »

San Francisco nonprofit developer HomeRise appoints Interim CEO, CFO - San Francisco Business TimesHomeRise, formerly Community Housing Partnership, oversees a portfolio of roughly 1,600 units in San Francisco and the Bay Area.
Fonte: SFBusinessTimes - 🏆 78. / 68 Consulte Mais informação »

Rezo Therapeutics, Prosper Marketplace score $75M venture rounds - Silicon Valley Business JournalThe Thanksgiving holiday didn't stop a drug developer and an online lender from each raising a large new round.
Fonte: svbizjournal - 🏆 334. / 59 Consulte Mais informação »

Crypto startup MoonPay hires Time president to lead its enterprise businessTime president Keith Grossman is leaving the legacy publisher to take on a new role as the president of enterprise at crypto trading platform MoonPay.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »